Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,082.08 +1.08 (+0.10%)

Streaming Delayed Price Updated: 11:29 AM EST, Jan 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

99 100 Next >

1 Reason Eli Lilly (LLY) Is One of the Best Healthcare Stocks You Can Buy Today ↗

October 14, 2025

Despite the company's run in recent years, it's not too late to buy.

Via The Motley Fool

Independence Bank of Kentucky Buys Another $3.1 Million Eli Lilly (NYSE: LLY) Shares ↗

October 14, 2025

Via The Motley Fool

Topics ETFs Regulatory Compliance

3 Healthcare Companies Insiders Are Buying ↗

October 14, 2025

Insiders are buying these three healthcare companies that have catalysts to drive their share prices higher in the upcoming years.

Via MarketBeat

Topics Initial Public Offering

FDA Approves Alzheimer’s Test Developed By Roche In Collaboration With Eli Lilly ↗

October 13, 2025

The blood-based test is aimed at aiding the initial assessment for Alzheimer’s disease and other causes of cognitive decline in the primary-care setting in patients aged 55 and older.

Via Stocktwits

Smart Money Is Betting Big In LLY Options ↗

October 10, 2025

Via Benzinga

Jim Cramer Declares Wall Street Divided: Three Distinct Markets Emerge

October 13, 2025

Wall Street, according to CNBC's Mad Money host Jim Cramer, is no longer a monolithic entity but rather a fractured landscape operating under three distinct economic realities. In recent broadcasts...

Via MarketMinute

Topics Artificial Intelligence Economy

Recent Filing Shows That Sen. John Boozman Bought Over $49K Worth of iShares 7-10 Year Treasury Bond ETF Stock ↗

October 13, 2025

Via Benzinga

Topics ETFs

Down 44%, Should You Buy the Dip on Viking Therapeutics? ↗

October 13, 2025

The company is readying to take on pharma giants Novo Nordisk and Eli Lilly.

Via The Motley Fool

Healthcare Opportunities And Risks Collide For Direxion's Eli Lilly-Focused ELIL, ELIS ETFs ↗

October 13, 2025

Via Benzinga

This Stock Is Up By 285% This Year But Could Still Jump By 53%, According to Wall Street ↗

October 13, 2025

Is it too late to get on the bandwagon?

Via The Motley Fool

The Smartest Growth Stock to Buy With $100 Right Now ↗

October 13, 2025

This beaten-down drugmaker is well positioned to turn things around.

Via The Motley Fool

Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? ↗

October 13, 2025

Now may be the time to invest in drug companies, as they just slipped the tariff noose.

Via The Motley Fool

Topics ETFs Government World Trade

Should You Buy Novo Nordisk Right Now? ↗

October 12, 2025

The fallen pharma giant could make a big comeback in 2026.

Via The Motley Fool

Should Investors Buy Eli Lilly Stock? ↗

October 11, 2025

Investors are excited about the company's weight loss treatments but might be overlooking the exciting pipeline of new therapies.

Via The Motley Fool

MarketBeat Week in Review – 10/06 - 10/10 ↗

October 11, 2025

Investors are eagerly awaiting the start of earnings season for market direction, as the continued government shutdown is creating a lack of economic data

Via MarketBeat

Topics Economy

Why Hims & Hers Health (HIMS) Stock Is Nosediving

October 10, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.5% in the afternoon session after a Bank of America report highlighted weakening order trends and a lowered fourth-quarter revenue...

Via StockStory

Topics World Trade

Bill Gates And PAHO Push To Make Weight-Loss Drugs Accessible In Low-Income Nations ↗

October 10, 2025

Bill Gates and PAHO are working to make weight-loss drugs like Wegovy and Mounjaro more affordable for low-income countries.

Via Benzinga

1 Vanguard ETF to Invest In That Can Turn $500 Monthly Into $800,000 ↗

October 10, 2025

This ETF has shown market-beating potential since its inception.

Via The Motley Fool

Topics ETFs

2 Pharmaceutical Stocks That Look Like No-Brainer Buys Right Now ↗

October 10, 2025

Ongoing developments make these companies look attractive.

Via The Motley Fool

Topics Economy World Trade

Pfizer (NYSE:PFE) Marks 348th Consecutive Dividend Payment: A Pillar of Stability Amidst Transformation

October 09, 2025

New York, NY – October 9, 2025 – Pfizer Inc. (NYSE:PFE) has once again affirmed its steadfast commitment to shareholder returns, declaring a $0.43 per-share cash dividend for the fourth quarter of...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Eli Lilly Completes Phase 1 Study for Bimagrumab and Tirzepatide Amidst Strategic Pipeline Revisions

October 09, 2025

Eli Lilly and Company (NYSE: LLY) has announced the completion of its Phase 1 bioavailability study for the combination of Bimagrumab and Tirzepatide on October 8, 2025, a foundational step in...

Via MarketMinute

Direxion's QQQU, QQQD ETFs Foster A Diversified Approach To Magnificent 7 Speculation ↗

October 09, 2025

Via Benzinga

Topics ETFs

5 Healthcare Plays Powering the Sector’s Big Comeback ↗

October 09, 2025

After years of lagging, the healthcare sector is showing signs of a turnaround driven by lower rates, policy clarity, and renewed investor interest.

Via MarketBeat

Watch Out Eli Lilly, This Pharma Giant Is Gunning to Be a Top Player in the Obesity Market ↗

October 09, 2025

Roche has a promising GLP-1 drug that is entering phase 3 trials.

Via The Motley Fool

Amazon's Dual Thrust: Prime Discounts and Pharmacy Expansion Reshape Retail and Healthcare Landscapes

October 08, 2025

Amazon (NASDAQ: AMZN) continues to aggressively expand its strategic business developments, solidifying its e-commerce dominance through frequent Prime discount events and making significant inroads...

Via MarketMinute

Topics Artificial Intelligence Economy

Recent Filing Shows That Rep. David Taylor Bought Over $5K Worth of Procter & Gamble Stock ↗

October 08, 2025

Via Benzinga

Eli Lilly To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

October 08, 2025

Via Benzinga

These 2 AI Stocks Could Surpass Oracle in Market Cap by 2030 ↗

October 08, 2025

Investors should buy stakes in AI-powered stocks with scalable, asset-light business models.

Via The Motley Fool

Topics Artificial Intelligence

Eli Lilly Stock Eases After-Hours: Ex-FDA Official Ejected By RFK Jr. Joins Firm — Will Investors Warm Up? ↗

October 07, 2025

Investors reacted to the company’s leadership shake-up and new data from its ulcerative colitis therapy Omvoh showing sustained remission over four years.

Via Stocktwits

Topics Government

Healthcare Sector Defies Broader Market Swings, Leads S&P 500 Momentum on October 7, 2025

October 07, 2025

On a day where the broader S&P 500 and Nasdaq Composite indices soared to new all-time record highs, the S&P 500 Healthcare sector presented a compelling, albeit nuanced, narrative of market leadership...

Via MarketMinute

Topics Artificial Intelligence ETFs Intellectual Property

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.